Understanding Pain in Pancreatic Cancer: The Role of LDH and IL-8
Author Information
Author(s): Zhiming Zhou, Zongfeng Guo, Xiaomin Lu, Xiaoqing Xu
Primary Institution: Nantong University, Affiliated Haian Hospital
Hypothesis
Serum LDH and IL-8 concentrations significantly correlate with the degree of pancreatic cancer pain.
Conclusion
LDH and IL-8 are involved in the pain aggravation process of pancreatic cancer and can serve as biological indicators for evaluating pain severity.
Supporting Evidence
- The serum LDH and IL-8 concentrations in the high-pain group were higher than in the low-pain group.
- Pearson correlation analysis revealed a positive correlation between serum LDH concentration and pain grading.
- LDH and IL-8 concentrations are independent risk factors for high pain levels.
Takeaway
This study found that two substances in the blood, LDH and IL-8, can help doctors understand how much pain someone with pancreatic cancer is feeling.
Methodology
Patients were divided into low and high pain groups based on a pain scale, and serum levels of LDH and IL-8 were measured and analyzed for correlation with pain severity.
Potential Biases
Potential biases may arise from the subjective nature of pain assessment and the selection criteria for participants.
Limitations
The study's findings may not be generalizable due to the specific patient population and sample size.
Participant Demographics
The study included 126 pancreatic cancer patients aged 18-75, with a mix of genders and a history of alcohol consumption.
Statistical Information
P-Value
P<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website